Makoto Hosoyamada

Title: **Inventor Spotlight: Makoto Hosoyamada**

Introduction

Makoto Hosoyamada is a notable inventor based in Mitaka, Japan, recognized for his contributions to the field of biotechnology. With a keen focus on transport proteins, his work has significant implications for drug development and safety.

Latest Patents

Hosoyamada holds a patent for a "Method for Screening Using an OAT1 Transporter Protein." This innovative patent involves a protein that can transport organic anions, specifically those with amino acid sequences represented by SEQ ID NO: 1 or 2, or derived sequences that may contain alterations such as deletions, substitutions, or additions of amino acids. The significance of this protein, along with the corresponding gene, lies in its application for in vitro analysis of drug release and interactions, particularly in developing methods to screen drugs that may help prevent nephrotoxicity.

Career Highlights

Throughout his career, Makoto Hosoyamada has been associated with various organizations that focus on advancing medical and biological science. One of the noteworthy companies he worked with is Fuji Bio Medix Co., Ltd., where he contributed his expertise in drug transport mechanisms and safety.

Collaborations

In his pursuit of innovative solutions, Hosoyamada has collaborated with prominent researchers such as Hitoshi Endou and Yoshikatsu Kanai. These collaborations reflect a collective effort to push the boundaries of understanding in drug transport and related fields.

Conclusion

Makoto Hosoyamada's inventive spirit and commitment to advancing biotechnology underscore his significance within the research community. His pioneering work, particularly concerning the OAT1 transporter protein, holds promise for enhancing drug safety and efficacy. As research in this area continues to evolve, Hosoyamada's contributions will likely remain influential in the ongoing quest to improve pharmaceutical outcomes.